Jing Li is an accomplished professional in bioanalytical sciences with extensive experience in method development and validation for quantitative analysis of siRNA compounds, heparin, and glycosaminoglycans. Currently serving as Director at Alnylam Pharmaceuticals since November 2015, Jing Li has progressed through various roles in the organization, contributing to the facilitation of method transfer to CROs for pharmacokinetic and toxicokinetic studies. Prior experience includes a Senior Scientist position at Blue Stream Laboratories, where analytical method development was provided to clients in biotechnology and pharmaceuticals, and a postdoctoral associate role at MIT focusing on glycomic profiling and cancer studies. Jing Li holds a Ph.D. in Chemistry from the University of Chicago and a B.S. in Chemistry from Tsinghua University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices